Can we achieve complete remission in locally advanced unresectable Hepatocellular Carcinoma (HCC) by using Sorafenib? Case report and review of literature from Qatar

• 作者: Kakil Ibrahim Rasul
• 来源期刊: 化疗(英文)
• 学科: 医学
• 关键词: HEPATOCELLULAR Ca SORAFENIB CHEMOEMBOLIZATION
• 年，卷（期）: 2012,（1）
• 页码范围: 1-4
• 页数: 4页
• 分类号: R73

摘要

Patients with HCC continue to have a dismal prognosis, with 1-year and 3-year survival rates of 36 and 17%, respectively. This is in part related to more than two-thirds of tumors being diagnosed at advanced stages, as well as a substantial portion of patients with early HCC failing to receive potentially curative treatments. Systemic therapy for advanced unresectable HCC limited until the discovery of sorafenib, we are reporting a 53 year patient with unresectable HCC achieved complete remission clinically, radiologically and biochemically with sorafenib which is the first case report.